{"entity":{"type":"insider","cik":"0001362155","url":"/insider/0001362155","json_url":"/insider/0001362155.json","name":"Douglas Earl Martin","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":40,"n_filings":11,"first":"2008-01-24","last":"2026-02-04","span_basis":"filed_date"},"name_variants":[{"name":"Douglas Earl Martin","source":"filing","n_filings":11,"first_seen":"2008-01-24","last_seen":"2026-02-04"}],"transactions":[{"id":5752888,"accession":"0001362155-26-000002","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001362155-26-000002","line_url":"/filing/0001362155-26-000002#line-1","is_derivative":false,"issuer_cik":"0001362155","issuer_name":"Allogene Therapeutics, Inc.","issuer_ticker":"ALLO","issuer_name_source":null,"issuer_url":"/issuer/0001362155","owner_cik":"0001362155","owner_name":"Douglas Earl Martin","owner_display_name":"Douglas Earl Martin","owner_url":"/insider/0001362155","role":"Officer (SVP, General Counsel)","role_mark":"O","role_mark_label":"Officer (SVP, General Counsel)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP, General Counsel","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":22900.0,"shares_display":"22,900","price_per_share":1.76,"price_display":"1.76","price_state":"stated","total_value":40304.0,"total_display":"40,304.00","total_whole":"40,304","shares_owned_after":564948.0,"shares_owned_after_display":"564,948","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-02-02","filed_date":"2026-02-04","scope":"insider"},{"id":4150869,"accession":"0001737287-25-000020","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001737287-25-000020","line_url":"/filing/0001737287-25-000020#line-1","is_derivative":false,"issuer_cik":"0001362155","issuer_name":"Allogene Therapeutics, Inc.","issuer_ticker":"ALLO","issuer_name_source":null,"issuer_url":"/issuer/0001362155","owner_cik":"0001362155","owner_name":"Douglas Earl Martin","owner_display_name":"Douglas Earl Martin","owner_url":"/insider/0001362155","role":"Officer (SVP, General Counsel)","role_mark":"O","role_mark_label":"Officer (SVP, General Counsel)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP, General Counsel","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":6404.0,"shares_display":"6,404","price_per_share":1.71,"price_display":"1.71","price_state":"stated","total_value":10950.84,"total_display":"10,950.84","total_whole":"10,951","shares_owned_after":587848.0,"shares_owned_after_display":"587,848","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-02-03","filed_date":"2025-02-05","scope":"insider"},{"id":3500515,"accession":"0001209191-12-020298","txn_seq":18,"anchor":"line-18","filing_url":"/filing/0001209191-12-020298","line_url":"/filing/0001209191-12-020298#line-18","is_derivative":false,"issuer_cik":"0001138400","issuer_name":"BIOMIMETIC THERAPEUTICS, INC.","issuer_ticker":"BMTI","issuer_name_source":null,"issuer_url":"/issuer/0001138400","owner_cik":"0001362155","owner_name":"Douglas Earl Martin","owner_display_name":"Douglas Earl Martin","owner_url":"/insider/0001362155","role":"Officer (General Counsel)","role_mark":"O","role_mark_label":"Officer (General Counsel)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"General Counsel","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":8000.0,"shares_display":"8,000","price_per_share":2.3528,"price_display":"2.35","price_state":"stated","total_value":18822.4,"total_display":"18,822.40","total_whole":"18,822","shares_owned_after":11056.0,"shares_owned_after_display":"11,056","ownership_form":"D","is_10b5_1":null,"transaction_date":"2012-03-28","filed_date":"2012-03-28","scope":"insider"},{"id":3500512,"accession":"0001209191-12-020298","txn_seq":17,"anchor":"line-17","filing_url":"/filing/0001209191-12-020298","line_url":"/filing/0001209191-12-020298#line-17","is_derivative":false,"issuer_cik":"0001138400","issuer_name":"BIOMIMETIC THERAPEUTICS, INC.","issuer_ticker":"BMTI","issuer_name_source":null,"issuer_url":"/issuer/0001138400","owner_cik":"0001362155","owner_name":"Douglas Earl Martin","owner_display_name":"Douglas Earl Martin","owner_url":"/insider/0001362155","role":"Officer (General Counsel)","role_mark":"O","role_mark_label":"Officer (General Counsel)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"General Counsel","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":6000.0,"shares_display":"6,000","price_per_share":2.35,"price_display":"2.35","price_state":"stated","total_value":14100.0,"total_display":"14,100.00","total_whole":"14,100","shares_owned_after":41517.0,"shares_owned_after_display":"41,517","ownership_form":"D","is_10b5_1":null,"transaction_date":"2012-03-28","filed_date":"2012-03-28","scope":"insider"},{"id":3500509,"accession":"0001209191-12-020298","txn_seq":16,"anchor":"line-16","filing_url":"/filing/0001209191-12-020298","line_url":"/filing/0001209191-12-020298#line-16","is_derivative":false,"issuer_cik":"0001138400","issuer_name":"BIOMIMETIC THERAPEUTICS, INC.","issuer_ticker":"BMTI","issuer_name_source":null,"issuer_url":"/issuer/0001138400","owner_cik":"0001362155","owner_name":"Douglas Earl Martin","owner_display_name":"Douglas Earl Martin","owner_url":"/insider/0001362155","role":"Officer (General Counsel)","role_mark":"O","role_mark_label":"Officer (General Counsel)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"General Counsel","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5000.0,"shares_display":"5,000","price_per_share":2.382,"price_display":"2.38","price_state":"stated","total_value":11910.0,"total_display":"11,910.00","total_whole":"11,910","shares_owned_after":19517.0,"shares_owned_after_display":"19,517","ownership_form":"D","is_10b5_1":null,"transaction_date":"2012-03-28","filed_date":"2012-03-28","scope":"insider"},{"id":3500506,"accession":"0001209191-12-020298","txn_seq":15,"anchor":"line-15","filing_url":"/filing/0001209191-12-020298","line_url":"/filing/0001209191-12-020298#line-15","is_derivative":false,"issuer_cik":"0001138400","issuer_name":"BIOMIMETIC THERAPEUTICS, INC.","issuer_ticker":"BMTI","issuer_name_source":null,"issuer_url":"/issuer/0001138400","owner_cik":"0001362155","owner_name":"Douglas Earl Martin","owner_display_name":"Douglas Earl Martin","owner_url":"/insider/0001362155","role":"Officer (General Counsel)","role_mark":"O","role_mark_label":"Officer (General Counsel)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"General Counsel","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5000.0,"shares_display":"5,000","price_per_share":2.37,"price_display":"2.37","price_state":"stated","total_value":11850.0,"total_display":"11,850.00","total_whole":"11,850","shares_owned_after":24517.0,"shares_owned_after_display":"24,517","ownership_form":"D","is_10b5_1":null,"transaction_date":"2012-03-28","filed_date":"2012-03-28","scope":"insider"},{"id":3500503,"accession":"0001209191-12-020298","txn_seq":14,"anchor":"line-14","filing_url":"/filing/0001209191-12-020298","line_url":"/filing/0001209191-12-020298#line-14","is_derivative":false,"issuer_cik":"0001138400","issuer_name":"BIOMIMETIC THERAPEUTICS, INC.","issuer_ticker":"BMTI","issuer_name_source":null,"issuer_url":"/issuer/0001138400","owner_cik":"0001362155","owner_name":"Douglas Earl Martin","owner_display_name":"Douglas Earl Martin","owner_url":"/insider/0001362155","role":"Officer (General Counsel)","role_mark":"O","role_mark_label":"Officer (General Counsel)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"General Counsel","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5000.0,"shares_display":"5,000","price_per_share":2.36,"price_display":"2.36","price_state":"stated","total_value":11800.0,"total_display":"11,800.00","total_whole":"11,800","shares_owned_after":33517.0,"shares_owned_after_display":"33,517","ownership_form":"D","is_10b5_1":null,"transaction_date":"2012-03-28","filed_date":"2012-03-28","scope":"insider"},{"id":3500500,"accession":"0001209191-12-020298","txn_seq":13,"anchor":"line-13","filing_url":"/filing/0001209191-12-020298","line_url":"/filing/0001209191-12-020298#line-13","is_derivative":false,"issuer_cik":"0001138400","issuer_name":"BIOMIMETIC THERAPEUTICS, INC.","issuer_ticker":"BMTI","issuer_name_source":null,"issuer_url":"/issuer/0001138400","owner_cik":"0001362155","owner_name":"Douglas Earl Martin","owner_display_name":"Douglas Earl Martin","owner_url":"/insider/0001362155","role":"Officer (General Counsel)","role_mark":"O","role_mark_label":"Officer (General Counsel)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"General Counsel","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5000.0,"shares_display":"5,000","price_per_share":2.35,"price_display":"2.35","price_state":"stated","total_value":11750.0,"total_display":"11,750.00","total_whole":"11,750","shares_owned_after":53517.0,"shares_owned_after_display":"53,517","ownership_form":"D","is_10b5_1":null,"transaction_date":"2012-03-28","filed_date":"2012-03-28","scope":"insider"},{"id":3500497,"accession":"0001209191-12-020298","txn_seq":12,"anchor":"line-12","filing_url":"/filing/0001209191-12-020298","line_url":"/filing/0001209191-12-020298#line-12","is_derivative":false,"issuer_cik":"0001138400","issuer_name":"BIOMIMETIC THERAPEUTICS, INC.","issuer_ticker":"BMTI","issuer_name_source":null,"issuer_url":"/issuer/0001138400","owner_cik":"0001362155","owner_name":"Douglas Earl Martin","owner_display_name":"Douglas Earl Martin","owner_url":"/insider/0001362155","role":"Officer (General Counsel)","role_mark":"O","role_mark_label":"Officer (General Counsel)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"General Counsel","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3300.0,"shares_display":"3,300","price_per_share":2.3401,"price_display":"2.34","price_state":"stated","total_value":7722.33,"total_display":"7,722.33","total_whole":"7,722","shares_owned_after":48917.0,"shares_owned_after_display":"48,917","ownership_form":"D","is_10b5_1":null,"transaction_date":"2012-03-28","filed_date":"2012-03-28","scope":"insider"},{"id":3500494,"accession":"0001209191-12-020298","txn_seq":11,"anchor":"line-11","filing_url":"/filing/0001209191-12-020298","line_url":"/filing/0001209191-12-020298#line-11","is_derivative":false,"issuer_cik":"0001138400","issuer_name":"BIOMIMETIC THERAPEUTICS, INC.","issuer_ticker":"BMTI","issuer_name_source":null,"issuer_url":"/issuer/0001138400","owner_cik":"0001362155","owner_name":"Douglas Earl Martin","owner_display_name":"Douglas Earl Martin","owner_url":"/insider/0001362155","role":"Officer (General Counsel)","role_mark":"O","role_mark_label":"Officer (General Counsel)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"General Counsel","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3000.0,"shares_display":"3,000","price_per_share":2.3413,"price_display":"2.34","price_state":"stated","total_value":7023.9,"total_display":"7,023.90","total_whole":"7,024","shares_owned_after":38517.0,"shares_owned_after_display":"38,517","ownership_form":"D","is_10b5_1":null,"transaction_date":"2012-03-28","filed_date":"2012-03-28","scope":"insider"},{"id":3500490,"accession":"0001209191-12-020298","txn_seq":10,"anchor":"line-10","filing_url":"/filing/0001209191-12-020298","line_url":"/filing/0001209191-12-020298#line-10","is_derivative":false,"issuer_cik":"0001138400","issuer_name":"BIOMIMETIC THERAPEUTICS, INC.","issuer_ticker":"BMTI","issuer_name_source":null,"issuer_url":"/issuer/0001138400","owner_cik":"0001362155","owner_name":"Douglas Earl Martin","owner_display_name":"Douglas Earl Martin","owner_url":"/insider/0001362155","role":"Officer (General Counsel)","role_mark":"O","role_mark_label":"Officer (General Counsel)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"General Counsel","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2000.0,"shares_display":"2,000","price_per_share":2.3601,"price_display":"2.36","price_state":"stated","total_value":4720.2,"total_display":"4,720.20","total_whole":"4,720","shares_owned_after":29517.0,"shares_owned_after_display":"29,517","ownership_form":"D","is_10b5_1":null,"transaction_date":"2012-03-28","filed_date":"2012-03-28","scope":"insider"},{"id":3500486,"accession":"0001209191-12-020298","txn_seq":9,"anchor":"line-9","filing_url":"/filing/0001209191-12-020298","line_url":"/filing/0001209191-12-020298#line-9","is_derivative":false,"issuer_cik":"0001138400","issuer_name":"BIOMIMETIC THERAPEUTICS, INC.","issuer_ticker":"BMTI","issuer_name_source":null,"issuer_url":"/issuer/0001138400","owner_cik":"0001362155","owner_name":"Douglas Earl Martin","owner_display_name":"Douglas Earl Martin","owner_url":"/insider/0001362155","role":"Officer (General Counsel)","role_mark":"O","role_mark_label":"Officer (General Counsel)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"General Counsel","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1400.0,"shares_display":"1,400","price_per_share":2.33,"price_display":"2.33","price_state":"stated","total_value":3262.0,"total_display":"3,262.00","total_whole":"3,262","shares_owned_after":47517.0,"shares_owned_after_display":"47,517","ownership_form":"D","is_10b5_1":null,"transaction_date":"2012-03-28","filed_date":"2012-03-28","scope":"insider"},{"id":3500483,"accession":"0001209191-12-020298","txn_seq":8,"anchor":"line-8","filing_url":"/filing/0001209191-12-020298","line_url":"/filing/0001209191-12-020298#line-8","is_derivative":false,"issuer_cik":"0001138400","issuer_name":"BIOMIMETIC THERAPEUTICS, INC.","issuer_ticker":"BMTI","issuer_name_source":null,"issuer_url":"/issuer/0001138400","owner_cik":"0001362155","owner_name":"Douglas Earl Martin","owner_display_name":"Douglas Earl Martin","owner_url":"/insider/0001362155","role":"Officer (General Counsel)","role_mark":"O","role_mark_label":"Officer (General Counsel)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"General Counsel","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1300.0,"shares_display":"1,300","price_per_share":2.35,"price_display":"2.35","price_state":"stated","total_value":3055.0,"total_display":"3,055.00","total_whole":"3,055","shares_owned_after":32217.0,"shares_owned_after_display":"32,217","ownership_form":"D","is_10b5_1":null,"transaction_date":"2012-03-28","filed_date":"2012-03-28","scope":"insider"},{"id":3500476,"accession":"0001209191-12-020298","txn_seq":7,"anchor":"line-7","filing_url":"/filing/0001209191-12-020298","line_url":"/filing/0001209191-12-020298#line-7","is_derivative":false,"issuer_cik":"0001138400","issuer_name":"BIOMIMETIC THERAPEUTICS, INC.","issuer_ticker":"BMTI","issuer_name_source":null,"issuer_url":"/issuer/0001138400","owner_cik":"0001362155","owner_name":"Douglas Earl Martin","owner_display_name":"Douglas Earl Martin","owner_url":"/insider/0001362155","role":"Officer (General Counsel)","role_mark":"O","role_mark_label":"Officer (General Counsel)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"General Counsel","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1100.0,"shares_display":"1,100","price_per_share":2.32,"price_display":"2.32","price_state":"stated","total_value":2552.0,"total_display":"2,552.00","total_whole":"2,552","shares_owned_after":52417.0,"shares_owned_after_display":"52,417","ownership_form":"D","is_10b5_1":null,"transaction_date":"2012-03-28","filed_date":"2012-03-28","scope":"insider"},{"id":3500475,"accession":"0001209191-12-020298","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001209191-12-020298","line_url":"/filing/0001209191-12-020298#line-6","is_derivative":false,"issuer_cik":"0001138400","issuer_name":"BIOMIMETIC THERAPEUTICS, INC.","issuer_ticker":"BMTI","issuer_name_source":null,"issuer_url":"/issuer/0001138400","owner_cik":"0001362155","owner_name":"Douglas Earl Martin","owner_display_name":"Douglas Earl Martin","owner_url":"/insider/0001362155","role":"Officer (General Counsel)","role_mark":"O","role_mark_label":"Officer (General Counsel)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"General Counsel","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":461.0,"shares_display":"461","price_per_share":2.371,"price_display":"2.37","price_state":"stated","total_value":1093.031,"total_display":"1,093.03","total_whole":"1,093","shares_owned_after":19056.0,"shares_owned_after_display":"19,056","ownership_form":"D","is_10b5_1":null,"transaction_date":"2012-03-28","filed_date":"2012-03-28","scope":"insider"},{"id":3500472,"accession":"0001209191-12-020298","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001209191-12-020298","line_url":"/filing/0001209191-12-020298#line-5","is_derivative":false,"issuer_cik":"0001138400","issuer_name":"BIOMIMETIC THERAPEUTICS, INC.","issuer_ticker":"BMTI","issuer_name_source":null,"issuer_url":"/issuer/0001138400","owner_cik":"0001362155","owner_name":"Douglas Earl Martin","owner_display_name":"Douglas Earl Martin","owner_url":"/insider/0001362155","role":"Officer (General Counsel)","role_mark":"O","role_mark_label":"Officer (General Counsel)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"General Counsel","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":400.0,"shares_display":"400","price_per_share":2.35,"price_display":"2.35","price_state":"stated","total_value":940.0,"total_display":"940.00","total_whole":"940","shares_owned_after":31817.0,"shares_owned_after_display":"31,817","ownership_form":"D","is_10b5_1":null,"transaction_date":"2012-03-28","filed_date":"2012-03-28","scope":"insider"},{"id":3500469,"accession":"0001209191-12-020298","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209191-12-020298","line_url":"/filing/0001209191-12-020298#line-4","is_derivative":false,"issuer_cik":"0001138400","issuer_name":"BIOMIMETIC THERAPEUTICS, INC.","issuer_ticker":"BMTI","issuer_name_source":null,"issuer_url":"/issuer/0001138400","owner_cik":"0001362155","owner_name":"Douglas Earl Martin","owner_display_name":"Douglas Earl Martin","owner_url":"/insider/0001362155","role":"Officer (General Counsel)","role_mark":"O","role_mark_label":"Officer (General Counsel)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"General Counsel","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":300.0,"shares_display":"300","price_per_share":2.35,"price_display":"2.35","price_state":"stated","total_value":705.0,"total_display":"705.00","total_whole":"705","shares_owned_after":31517.0,"shares_owned_after_display":"31,517","ownership_form":"D","is_10b5_1":null,"transaction_date":"2012-03-28","filed_date":"2012-03-28","scope":"insider"},{"id":3500465,"accession":"0001209191-12-020298","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-12-020298","line_url":"/filing/0001209191-12-020298#line-3","is_derivative":false,"issuer_cik":"0001138400","issuer_name":"BIOMIMETIC THERAPEUTICS, INC.","issuer_ticker":"BMTI","issuer_name_source":null,"issuer_url":"/issuer/0001138400","owner_cik":"0001362155","owner_name":"Douglas Earl Martin","owner_display_name":"Douglas Earl Martin","owner_url":"/insider/0001362155","role":"Officer (General Counsel)","role_mark":"O","role_mark_label":"Officer (General Counsel)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"General Counsel","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":200.0,"shares_display":"200","price_per_share":2.33,"price_display":"2.33","price_state":"stated","total_value":466.0,"total_display":"466.00","total_whole":"466","shares_owned_after":52217.0,"shares_owned_after_display":"52,217","ownership_form":"D","is_10b5_1":null,"transaction_date":"2012-03-28","filed_date":"2012-03-28","scope":"insider"},{"id":3500462,"accession":"0001209191-12-020298","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-12-020298","line_url":"/filing/0001209191-12-020298#line-2","is_derivative":false,"issuer_cik":"0001138400","issuer_name":"BIOMIMETIC THERAPEUTICS, INC.","issuer_ticker":"BMTI","issuer_name_source":null,"issuer_url":"/issuer/0001138400","owner_cik":"0001362155","owner_name":"Douglas Earl Martin","owner_display_name":"Douglas Earl Martin","owner_url":"/insider/0001362155","role":"Officer (General Counsel)","role_mark":"O","role_mark_label":"Officer (General Counsel)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"General Counsel","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5000.0,"shares_display":"5,000","price_per_share":2.34,"price_display":"2.34","price_state":"stated","total_value":11700.0,"total_display":"11,700.00","total_whole":"11,700","shares_owned_after":58517.0,"shares_owned_after_display":"58,517","ownership_form":"D","is_10b5_1":null,"transaction_date":"2012-03-27","filed_date":"2012-03-28","scope":"insider"},{"id":3500458,"accession":"0001209191-12-020298","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-12-020298","line_url":"/filing/0001209191-12-020298#line-1","is_derivative":false,"issuer_cik":"0001138400","issuer_name":"BIOMIMETIC THERAPEUTICS, INC.","issuer_ticker":"BMTI","issuer_name_source":null,"issuer_url":"/issuer/0001138400","owner_cik":"0001362155","owner_name":"Douglas Earl Martin","owner_display_name":"Douglas Earl Martin","owner_url":"/insider/0001362155","role":"Officer (General Counsel)","role_mark":"O","role_mark_label":"Officer (General Counsel)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"General Counsel","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1100.0,"shares_display":"1,100","price_per_share":2.35,"price_display":"2.35","price_state":"stated","total_value":2585.0,"total_display":"2,585.00","total_whole":"2,585","shares_owned_after":63517.0,"shares_owned_after_display":"63,517","ownership_form":"D","is_10b5_1":null,"transaction_date":"2012-03-26","filed_date":"2012-03-28","scope":"insider"},{"id":9075267,"accession":"0001209191-11-051774","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-11-051774","line_url":"/filing/0001209191-11-051774#line-3","is_derivative":false,"issuer_cik":"0001138400","issuer_name":"BIOMIMETIC THERAPEUTICS, INC.","issuer_ticker":"BMTI","issuer_name_source":null,"issuer_url":"/issuer/0001138400","owner_cik":"0001362155","owner_name":"Douglas Earl Martin","owner_display_name":"Douglas Earl Martin","owner_url":"/insider/0001362155","role":"Officer (General Counsel)","role_mark":"O","role_mark_label":"Officer (General Counsel)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"General Counsel","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3000.0,"shares_display":"3,000","price_per_share":3.0555,"price_display":"3.06","price_state":"stated","total_value":9166.5,"total_display":"9,166.50","total_whole":"9,167","shares_owned_after":57144.0,"shares_owned_after_display":"57,144","ownership_form":"D","is_10b5_1":null,"transaction_date":"2011-10-14","filed_date":"2011-10-14","scope":"insider"},{"id":9075266,"accession":"0001209191-11-051774","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-11-051774","line_url":"/filing/0001209191-11-051774#line-2","is_derivative":false,"issuer_cik":"0001138400","issuer_name":"BIOMIMETIC THERAPEUTICS, INC.","issuer_ticker":"BMTI","issuer_name_source":null,"issuer_url":"/issuer/0001138400","owner_cik":"0001362155","owner_name":"Douglas Earl Martin","owner_display_name":"Douglas Earl Martin","owner_url":"/insider/0001362155","role":"Officer (General Counsel)","role_mark":"O","role_mark_label":"Officer (General Counsel)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"General Counsel","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3000.0,"shares_display":"3,000","price_per_share":2.9805,"price_display":"2.98","price_state":"stated","total_value":8941.5,"total_display":"8,941.50","total_whole":"8,942","shares_owned_after":60144.0,"shares_owned_after_display":"60,144","ownership_form":"D","is_10b5_1":null,"transaction_date":"2011-10-13","filed_date":"2011-10-14","scope":"insider"},{"id":9075265,"accession":"0001209191-11-051774","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-11-051774","line_url":"/filing/0001209191-11-051774#line-1","is_derivative":false,"issuer_cik":"0001138400","issuer_name":"BIOMIMETIC THERAPEUTICS, INC.","issuer_ticker":"BMTI","issuer_name_source":null,"issuer_url":"/issuer/0001138400","owner_cik":"0001362155","owner_name":"Douglas Earl Martin","owner_display_name":"Douglas Earl Martin","owner_url":"/insider/0001362155","role":"Officer (General Counsel)","role_mark":"O","role_mark_label":"Officer (General Counsel)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"General Counsel","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3000.0,"shares_display":"3,000","price_per_share":2.9903,"price_display":"2.99","price_state":"stated","total_value":8970.9,"total_display":"8,970.90","total_whole":"8,971","shares_owned_after":63144.0,"shares_owned_after_display":"63,144","ownership_form":"D","is_10b5_1":null,"transaction_date":"2011-10-12","filed_date":"2011-10-14","scope":"insider"},{"id":9182698,"accession":"0001209191-11-051455","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209191-11-051455","line_url":"/filing/0001209191-11-051455#line-4","is_derivative":false,"issuer_cik":"0001138400","issuer_name":"BIOMIMETIC THERAPEUTICS, INC.","issuer_ticker":"BMTI","issuer_name_source":null,"issuer_url":"/issuer/0001138400","owner_cik":"0001362155","owner_name":"Douglas Earl Martin","owner_display_name":"Douglas Earl Martin","owner_url":"/insider/0001362155","role":"Officer (General Counsel)","role_mark":"O","role_mark_label":"Officer (General Counsel)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"General Counsel","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3000.0,"shares_display":"3,000","price_per_share":3.0052,"price_display":"3.01","price_state":"stated","total_value":9015.6,"total_display":"9,015.60","total_whole":"9,016","shares_owned_after":66144.0,"shares_owned_after_display":"66,144","ownership_form":"D","is_10b5_1":null,"transaction_date":"2011-10-11","filed_date":"2011-10-11","scope":"insider"},{"id":9182697,"accession":"0001209191-11-051455","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-11-051455","line_url":"/filing/0001209191-11-051455#line-3","is_derivative":false,"issuer_cik":"0001138400","issuer_name":"BIOMIMETIC THERAPEUTICS, INC.","issuer_ticker":"BMTI","issuer_name_source":null,"issuer_url":"/issuer/0001138400","owner_cik":"0001362155","owner_name":"Douglas Earl Martin","owner_display_name":"Douglas Earl Martin","owner_url":"/insider/0001362155","role":"Officer (General Counsel)","role_mark":"O","role_mark_label":"Officer (General Counsel)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"General Counsel","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3000.0,"shares_display":"3,000","price_per_share":2.9702,"price_display":"2.97","price_state":"stated","total_value":8910.6,"total_display":"8,910.60","total_whole":"8,911","shares_owned_after":69144.0,"shares_owned_after_display":"69,144","ownership_form":"D","is_10b5_1":null,"transaction_date":"2011-10-10","filed_date":"2011-10-11","scope":"insider"},{"id":9182696,"accession":"0001209191-11-051455","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-11-051455","line_url":"/filing/0001209191-11-051455#line-2","is_derivative":false,"issuer_cik":"0001138400","issuer_name":"BIOMIMETIC THERAPEUTICS, INC.","issuer_ticker":"BMTI","issuer_name_source":null,"issuer_url":"/issuer/0001138400","owner_cik":"0001362155","owner_name":"Douglas Earl Martin","owner_display_name":"Douglas Earl Martin","owner_url":"/insider/0001362155","role":"Officer (General Counsel)","role_mark":"O","role_mark_label":"Officer (General Counsel)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"General Counsel","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3000.0,"shares_display":"3,000","price_per_share":3.0155,"price_display":"3.02","price_state":"stated","total_value":9046.5,"total_display":"9,046.50","total_whole":"9,047","shares_owned_after":72144.0,"shares_owned_after_display":"72,144","ownership_form":"D","is_10b5_1":null,"transaction_date":"2011-10-07","filed_date":"2011-10-11","scope":"insider"},{"id":9182695,"accession":"0001209191-11-051455","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-11-051455","line_url":"/filing/0001209191-11-051455#line-1","is_derivative":false,"issuer_cik":"0001138400","issuer_name":"BIOMIMETIC THERAPEUTICS, INC.","issuer_ticker":"BMTI","issuer_name_source":null,"issuer_url":"/issuer/0001138400","owner_cik":"0001362155","owner_name":"Douglas Earl Martin","owner_display_name":"Douglas Earl Martin","owner_url":"/insider/0001362155","role":"Officer (General Counsel)","role_mark":"O","role_mark_label":"Officer (General Counsel)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"General Counsel","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3000.0,"shares_display":"3,000","price_per_share":2.9883,"price_display":"2.99","price_state":"stated","total_value":8964.9,"total_display":"8,964.90","total_whole":"8,965","shares_owned_after":75144.0,"shares_owned_after_display":"75,144","ownership_form":"D","is_10b5_1":null,"transaction_date":"2011-10-06","filed_date":"2011-10-11","scope":"insider"},{"id":9037541,"accession":"0001209191-11-050774","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-11-050774","line_url":"/filing/0001209191-11-050774#line-3","is_derivative":false,"issuer_cik":"0001138400","issuer_name":"BIOMIMETIC THERAPEUTICS, INC.","issuer_ticker":"BMTI","issuer_name_source":null,"issuer_url":"/issuer/0001138400","owner_cik":"0001362155","owner_name":"Douglas Earl Martin","owner_display_name":"Douglas Earl Martin","owner_url":"/insider/0001362155","role":"Officer (General Counsel)","role_mark":"O","role_mark_label":"Officer (General Counsel)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"General Counsel","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3000.0,"shares_display":"3,000","price_per_share":2.9454,"price_display":"2.95","price_state":"stated","total_value":8836.2,"total_display":"8,836.20","total_whole":"8,836","shares_owned_after":78144.0,"shares_owned_after_display":"78,144","ownership_form":"D","is_10b5_1":null,"transaction_date":"2011-10-05","filed_date":"2011-10-05","scope":"insider"},{"id":9037540,"accession":"0001209191-11-050774","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-11-050774","line_url":"/filing/0001209191-11-050774#line-2","is_derivative":false,"issuer_cik":"0001138400","issuer_name":"BIOMIMETIC THERAPEUTICS, INC.","issuer_ticker":"BMTI","issuer_name_source":null,"issuer_url":"/issuer/0001138400","owner_cik":"0001362155","owner_name":"Douglas Earl Martin","owner_display_name":"Douglas Earl Martin","owner_url":"/insider/0001362155","role":"Officer (General Counsel)","role_mark":"O","role_mark_label":"Officer (General Counsel)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"General Counsel","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3000.0,"shares_display":"3,000","price_per_share":2.8928,"price_display":"2.89","price_state":"stated","total_value":8678.4,"total_display":"8,678.40","total_whole":"8,678","shares_owned_after":81144.0,"shares_owned_after_display":"81,144","ownership_form":"D","is_10b5_1":null,"transaction_date":"2011-10-04","filed_date":"2011-10-05","scope":"insider"},{"id":9037539,"accession":"0001209191-11-050774","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-11-050774","line_url":"/filing/0001209191-11-050774#line-1","is_derivative":false,"issuer_cik":"0001138400","issuer_name":"BIOMIMETIC THERAPEUTICS, INC.","issuer_ticker":"BMTI","issuer_name_source":null,"issuer_url":"/issuer/0001138400","owner_cik":"0001362155","owner_name":"Douglas Earl Martin","owner_display_name":"Douglas Earl Martin","owner_url":"/insider/0001362155","role":"Officer (General Counsel)","role_mark":"O","role_mark_label":"Officer (General Counsel)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"General Counsel","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3000.0,"shares_display":"3,000","price_per_share":2.9188,"price_display":"2.92","price_state":"stated","total_value":8756.4,"total_display":"8,756.40","total_whole":"8,756","shares_owned_after":84144.0,"shares_owned_after_display":"84,144","ownership_form":"D","is_10b5_1":null,"transaction_date":"2011-10-03","filed_date":"2011-10-05","scope":"insider"},{"id":7716544,"accession":"0001209191-10-017968","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001209191-10-017968","line_url":"/filing/0001209191-10-017968#line-5","is_derivative":false,"issuer_cik":"0001138400","issuer_name":"BIOMIMETIC THERAPEUTICS, INC.","issuer_ticker":"BMTI","issuer_name_source":null,"issuer_url":"/issuer/0001138400","owner_cik":"0001362155","owner_name":"Douglas Earl Martin","owner_display_name":"Douglas Earl Martin","owner_url":"/insider/0001362155","role":"Officer (General Counsel)","role_mark":"O","role_mark_label":"Officer (General Counsel)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"General Counsel","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4430.0,"shares_display":"4,430","price_per_share":13.3,"price_display":"13.30","price_state":"stated","total_value":58919.0,"total_display":"58,919.00","total_whole":"58,919","shares_owned_after":83256.0,"shares_owned_after_display":"83,256","ownership_form":"D","is_10b5_1":null,"transaction_date":"2010-03-17","filed_date":"2010-03-19","scope":"insider"},{"id":7716542,"accession":"0001209191-10-017968","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209191-10-017968","line_url":"/filing/0001209191-10-017968#line-4","is_derivative":false,"issuer_cik":"0001138400","issuer_name":"BIOMIMETIC THERAPEUTICS, INC.","issuer_ticker":"BMTI","issuer_name_source":null,"issuer_url":"/issuer/0001138400","owner_cik":"0001362155","owner_name":"Douglas Earl Martin","owner_display_name":"Douglas Earl Martin","owner_url":"/insider/0001362155","role":"Officer (General Counsel)","role_mark":"O","role_mark_label":"Officer (General Counsel)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"General Counsel","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":570.0,"shares_display":"570","price_per_share":13.3009,"price_display":"13.30","price_state":"stated","total_value":7581.513,"total_display":"7,581.51","total_whole":"7,582","shares_owned_after":82686.0,"shares_owned_after_display":"82,686","ownership_form":"D","is_10b5_1":null,"transaction_date":"2010-03-17","filed_date":"2010-03-19","scope":"insider"},{"id":7388909,"accession":"0001209191-10-003231","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001209191-10-003231","line_url":"/filing/0001209191-10-003231#line-5","is_derivative":false,"issuer_cik":"0001138400","issuer_name":"BIOMIMETIC THERAPEUTICS, INC.","issuer_ticker":"BMTI","issuer_name_source":null,"issuer_url":"/issuer/0001138400","owner_cik":"0001362155","owner_name":"Douglas Earl Martin","owner_display_name":"Douglas Earl Martin","owner_url":"/insider/0001362155","role":"Officer (General Counsel)","role_mark":"O","role_mark_label":"Officer (General Counsel)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"General Counsel","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":12500.0,"shares_display":"12,500","price_per_share":12.1,"price_display":"12.10","price_state":"stated","total_value":151250.0,"total_display":"151,250.00","total_whole":"151,250","shares_owned_after":31901.0,"shares_owned_after_display":"31,901","ownership_form":"D","is_10b5_1":null,"transaction_date":"2010-01-13","filed_date":"2010-01-14","scope":"insider"},{"id":7388907,"accession":"0001209191-10-003231","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209191-10-003231","line_url":"/filing/0001209191-10-003231#line-4","is_derivative":false,"issuer_cik":"0001138400","issuer_name":"BIOMIMETIC THERAPEUTICS, INC.","issuer_ticker":"BMTI","issuer_name_source":null,"issuer_url":"/issuer/0001138400","owner_cik":"0001362155","owner_name":"Douglas Earl Martin","owner_display_name":"Douglas Earl Martin","owner_url":"/insider/0001362155","role":"Officer (General Counsel)","role_mark":"O","role_mark_label":"Officer (General Counsel)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"General Counsel","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":299.0,"shares_display":"299","price_per_share":12.1401,"price_display":"12.14","price_state":"stated","total_value":3629.8899,"total_display":"3,629.89","total_whole":"3,630","shares_owned_after":31602.0,"shares_owned_after_display":"31,602","ownership_form":"D","is_10b5_1":null,"transaction_date":"2010-01-13","filed_date":"2010-01-14","scope":"insider"},{"id":6082076,"accession":"0001209191-09-017076","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-09-017076","line_url":"/filing/0001209191-09-017076#line-1","is_derivative":false,"issuer_cik":"0001138400","issuer_name":"BIOMIMETIC THERAPEUTICS, INC.","issuer_ticker":"BMTI","issuer_name_source":null,"issuer_url":"/issuer/0001138400","owner_cik":"0001362155","owner_name":"Douglas Earl Martin","owner_display_name":"Douglas Earl Martin","owner_url":"/insider/0001362155","role":"Officer (General Counsel)","role_mark":"O","role_mark_label":"Officer (General Counsel)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"General Counsel","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1200.0,"shares_display":"1,200","price_per_share":8.45,"price_display":"8.45","price_state":"stated","total_value":10140.0,"total_display":"10,140.00","total_whole":"10,140","shares_owned_after":16099.0,"shares_owned_after_display":"16,099","ownership_form":"D","is_10b5_1":null,"transaction_date":"2009-03-17","filed_date":"2009-03-18","scope":"insider"},{"id":3582787,"accession":"0001209191-08-020902","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-08-020902","line_url":"/filing/0001209191-08-020902#line-1","is_derivative":false,"issuer_cik":"0001138400","issuer_name":"BIOMIMETIC THERAPEUTICS, INC.","issuer_ticker":"BMTI","issuer_name_source":null,"issuer_url":"/issuer/0001138400","owner_cik":"0001362155","owner_name":"Douglas Earl Martin","owner_display_name":"Douglas Earl Martin","owner_url":"/insider/0001362155","role":"Officer (General Counsel)","role_mark":"O","role_mark_label":"Officer (General Counsel)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"General Counsel","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1000.0,"shares_display":"1,000","price_per_share":9.05,"price_display":"9.05","price_state":"stated","total_value":9050.0,"total_display":"9,050.00","total_whole":"9,050","shares_owned_after":6493.0,"shares_owned_after_display":"6,493","ownership_form":"D","is_10b5_1":null,"transaction_date":"2008-03-28","filed_date":"2008-04-01","scope":"insider"},{"id":3764857,"accession":"0001209191-08-005242","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209191-08-005242","line_url":"/filing/0001209191-08-005242#line-4","is_derivative":false,"issuer_cik":"0001138400","issuer_name":"BIOMIMETIC THERAPEUTICS, INC.","issuer_ticker":"BMTI","issuer_name_source":null,"issuer_url":"/issuer/0001138400","owner_cik":"0001362155","owner_name":"Douglas Earl Martin","owner_display_name":"Douglas Earl Martin","owner_url":"/insider/0001362155","role":"Officer (General Counsel)","role_mark":"O","role_mark_label":"Officer (General Counsel)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"General Counsel","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":2900.0,"shares_display":"2,900","price_per_share":15.3,"price_display":"15.30","price_state":"stated","total_value":44370.0,"total_display":"44,370.00","total_whole":"44,370","shares_owned_after":4893.0,"shares_owned_after_display":"4,893","ownership_form":"D","is_10b5_1":null,"transaction_date":"2008-01-23","filed_date":"2008-01-24","scope":"insider"},{"id":3764855,"accession":"0001209191-08-005242","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-08-005242","line_url":"/filing/0001209191-08-005242#line-3","is_derivative":false,"issuer_cik":"0001138400","issuer_name":"BIOMIMETIC THERAPEUTICS, INC.","issuer_ticker":"BMTI","issuer_name_source":null,"issuer_url":"/issuer/0001138400","owner_cik":"0001362155","owner_name":"Douglas Earl Martin","owner_display_name":"Douglas Earl Martin","owner_url":"/insider/0001362155","role":"Officer (General Counsel)","role_mark":"O","role_mark_label":"Officer (General Counsel)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"General Counsel","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":300.0,"shares_display":"300","price_per_share":15.19,"price_display":"15.19","price_state":"stated","total_value":4557.0,"total_display":"4,557.00","total_whole":"4,557","shares_owned_after":5493.0,"shares_owned_after_display":"5,493","ownership_form":"D","is_10b5_1":null,"transaction_date":"2008-01-23","filed_date":"2008-01-24","scope":"insider"},{"id":3764853,"accession":"0001209191-08-005242","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-08-005242","line_url":"/filing/0001209191-08-005242#line-2","is_derivative":false,"issuer_cik":"0001138400","issuer_name":"BIOMIMETIC THERAPEUTICS, INC.","issuer_ticker":"BMTI","issuer_name_source":null,"issuer_url":"/issuer/0001138400","owner_cik":"0001362155","owner_name":"Douglas Earl Martin","owner_display_name":"Douglas Earl Martin","owner_url":"/insider/0001362155","role":"Officer (General Counsel)","role_mark":"O","role_mark_label":"Officer (General Counsel)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"General Counsel","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":200.0,"shares_display":"200","price_per_share":15.2,"price_display":"15.20","price_state":"stated","total_value":3040.0,"total_display":"3,040.00","total_whole":"3,040","shares_owned_after":5193.0,"shares_owned_after_display":"5,193","ownership_form":"D","is_10b5_1":null,"transaction_date":"2008-01-23","filed_date":"2008-01-24","scope":"insider"},{"id":3764851,"accession":"0001209191-08-005242","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-08-005242","line_url":"/filing/0001209191-08-005242#line-1","is_derivative":false,"issuer_cik":"0001138400","issuer_name":"BIOMIMETIC THERAPEUTICS, INC.","issuer_ticker":"BMTI","issuer_name_source":null,"issuer_url":"/issuer/0001138400","owner_cik":"0001362155","owner_name":"Douglas Earl Martin","owner_display_name":"Douglas Earl Martin","owner_url":"/insider/0001362155","role":"Officer (General Counsel)","role_mark":"O","role_mark_label":"Officer (General Counsel)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"General Counsel","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":100.0,"shares_display":"100","price_per_share":15.26,"price_display":"15.26","price_state":"stated","total_value":1526.0,"total_display":"1,526.00","total_whole":"1,526","shares_owned_after":4993.0,"shares_owned_after_display":"4,993","ownership_form":"D","is_10b5_1":null,"transaction_date":"2008-01-23","filed_date":"2008-01-24","scope":"insider"}],"next_cursor":null,"ledger_fault":false,"count":{"value":40,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":5,"open_market":true},{"code":"S","label":"Open-market sale","n":35,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":40},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001737287","name":"Allogene Therapeutics, Inc.","url":"/issuer/0001737287","role":"Officer (SVP, General Counsel)","n_filings":2,"first_seen":"2025-02-05","last_seen":"2026-02-04"},{"type":"issuer","type_label":"ISSUER","cik":"0001138400","name":"BIOMIMETIC THERAPEUTICS, INC.","url":"/issuer/0001138400","role":"Officer (General Counsel)","n_filings":9,"first_seen":"2008-01-24","last_seen":"2012-03-28"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001362155","retrieved_at":"2026-08-22T05:13:37+00:00","coverage":{"filings":1505395,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-20","last_ingest":"2026-08-21T05:23:33.898496+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}